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Am J Med Genet Part A 173A:914–929.Jointhypermobility syndrome(JHS)andEhlers–Danlos syndrome,
hypermobility type (EDS–HT) are two overlapping heritable dis-
orders (JHS/EDS–HT) recognized by separated sets of diagnostic
criteria and still lack a confirmatory test. This descriptive research
was aimed at better characterizing the clinical phenotype of JHS/
EDS–HTwith focus on available diagnostic criteria, and in order to
proposenovel features andassessment strategies.Onehundredand
eighty-nine (163 females, 26 males; age: 2–73 years) patients from
two Italian reference centers were investigated for Beighton score,
rangeofmotion in21additional joints, rate andsitesofdislocations
and sprains, recurrent soft-tissue injuries, tendon and muscle
ruptures, bodymass index, arm span/height ratio,wrist and thumb
signs, and 12 additional orthopedic features. Rough rates were
compared by age, sex, and handedness with a series of parametric
and non-parametric tools. Multiple correspondence analysis was
carried out for possible co-segregations of features. Beighton score
and hypermobility at other joints were influenced by age at diag-
nosis. Rate and sites of joint instability complications did not vary
according to age at diagnosis except for soft-tissue injuries. No
major difference was registered by sex and dominant versus non-
dominant body side. Atmultiple correspondence analysis, selected
features tend to co-segregate in a dichotomous distribution. Doli-
chostenomelia and arachnodactyly segregated independently. This
study pointed out amore proteanmusculoskeletal phenotype than
previously considered according to available diagnostic criteria for
JHS/EDS–HT.Ourfindingscorroborated theneed forare-thinking
of JHS/EDS–HT on clinical grounds in order to find better thera-
peutic and research strategies.  2017 Wiley Periodicals, Inc.
Key words: Beighton score; diagnostic criteria; dislocations;
Ehlers–Danlos syndrome; joint hypermobility; Marfanoid habitus2017 Wiley Periodicals, Inc.INTRODUCTION
Joint hypermobility syndrome (JHS) is a still neglected, heritable
disorder coupling generalized joint hypermobility (GJH) with
variable consequences of joint instability, musculoskeletal pain,914
MORLINO ET AL. 915and subtle skin features [Grahame et al., 2000]. Since the first
report of GJH as a recognizable feature and the delineation of the
Beighton score (BS [Kirk et al., 1967; Beighton et al., 1973]), our
knowledge on the clinical impact of GJH is markedly changed.
From the first attempt of defining GJH “benign” because it was
originally thought associated with few consequences of a harm-
less body built or a physical asset, GJH is now increasingly
re-interpreted as the “tip of the iceberg” of present or prospective
systemic disorders. Among them, JHS is emerging as the most
common condition, but its significant overlap with the appar-
ently rarer Ehlers–Danlos syndrome hypermobility type
(EDS–HT) inflames the scientific community [Castori and
Colombi, 2015]. To date, many researchers and practitioners
consider JHS and EDS–HT undistinguishable at the clinical level
[Tinkle et al., 2009]. Although we are still waiting for the
identification of the molecular basis of JHS and EDS–HT [De
Paepe and Malfait, 2012; Mayer et al., 2013], there is increasing
evidence for the co-segregation of JHS and EDS–HT as a single
trait with variable expressivity in the familial cases (i.e., JHS/
EDS–HT) [Tinkle et al., 2009; Castori et al., 2014a].
Different sets of criteria are being used for diagnosing JHS
(Brighton) and EDS–HT (Villefranche) [Beighton et al., 1998;
Grahame et al., 2000]. Their overlap is notable as both include a
high BS, pain, dislocations, and skin changes. However, differ-
ences exist concerning the definition of these criteria in the two
sets. This probably reflects the different perspectives of the
medical communities by whom they were originally delineated
(i.e., rheumatologists for JHS, pediatricians and geneticists for
EDS–HT) and the different populations in which these two
diagnoses are more commonly ascertained (i.e., women for
JHS and children for EDS–HT) [Tinkle et al., 2009]. In the
last decade, the number of patients attending specialized clinics is
increasing with an urgent need for standardizing diagnosis and
management [Rombaut et al., 2015a; Palmer et al., 2016]. The
original sets of criteria raised from an “opinion”-based approach
from the converging experience of a few experts. Conversely, in
the last years, many papers refine some of the previously identi-
fied pleiotropic features of the syndrome, such as the mucocuta-
neous and ocular involvement [Gharbiya et al., 2012; Castori
et al., 2015], and underline other entirely novel manifestations,
such as gastrointestinal involvement and autonomic dysfunction
[Zarate et al., 2010; De Wandele et al., 2014]. The role of fatigue
and chronic pain is also emphasized in JHS/EDS–HT [Voermans
et al., 2010a,b; Voermans and Knoop, 2011]. While many articles
offer a global impact of these features in JHS/EDS–HT, the
observation of families and heterogeneous patients’ cohorts
suggest an age-influenced phenotype [Castori et al., 2010a,
2011, 2013, 2014a, 2015]. Nevertheless, though originally con-
sidered relevant features, little attention was put on the extent
and evolution of anthropometry, consequences of joint instabil-
ity and orthopedic traits in JHS/EDS–HT.
This is the first study systematically assessing anthropometry,
orthopedic trait and distribution of whole-body joint hypermobil-
ity in JHS/EDS–HT. Data were extracted retrospectively from the
medical records of 189 JHS/EDS–HT patients evaluated in two
Italian expert centers for systemic hereditary connective tissue
disorders. Our results could contribute to a better definition ofthe physical phenotype of JHS/EDS–HT and to refine its clinical
diagnostic criteria for a prompt recognition of the disorder.PATIENTS AND METHODS
This study was intended as a bi-centric, retrospective research
gathering clinical data from two Italian centers for the diagnosis
and management of systemic hereditary connective tissue disor-
ders, particularly Ehlers–Danlos syndromes. The center with the
highest number of patients lead the study and was considered the
training center (TC). Data were then compared with the second
center, which was named validation center (VC). All patients gave
their informed consent to the study. This study was in accordance
with the Helsinki Declaration of 1975, as revised in 1983.Patients’ Selection and Phenotype Definition
Patients of the TC were selected from the jointed service for joint
hypermobility andEhlers–Danlos syndromeat theMedicalGenetics
Outpatient Service of the SanCamillo–ForlaniniHospital and at the
Physical Medicine and Rehabilitation Center of the Policlinico
Umberto I University Hospital in Rome. Patients of the VC were
enrolled from the Center for the Diagnosis and Management of
Ehlers–Danlos syndromes and Hereditary Connective Tissue Dis-
orders at the University of Brescia and Spedali Civili University
Hospital in Brescia. All patients underwent a direct clinical evalua-
tion aimed at extensively defining the phenotype and associated
management issues. The general assessment followed standard
procedures as previously described [Castori et al., 2014a, 2015].
In brief, all patients were evaluated for the available clinical diag-
nostic criteria for JHS (Brighton criteria) [Grahame et al., 2000] and
Ehlers–Danlos syndrome (Villefranche criteria) [Beighton et al.,
1998]. When necessary, other sets of criteria for cognate disorders,
such as the revisedGhent criteria forMarfan syndrome [Loeys et al.,
2010] were also applied. Differential diagnosis included heart ultra-
sound and ophthalmological survey and, when necessary, bone
densitometry and spine and brain MRI, as well as a non-invasive
assessment of the vascular tree, according to the recently published
Italian diagnostic approach for Ehlers–Danlos syndromes [Castori
and Colombi, 2016]. In case of persistent doubts concerning the
overlap with other hereditary connective tissue disorders (in partic-
ular, vascular and classical EDS, and Loeys–Dietz syndromes),
appropriate molecular studies were performed by the national
reference laboratory for the molecular diagnosis of EDS and related
conditions (Brescia). However, supplementary molecular studies
were carried out in a few patients andmost cases were limited to the
exclusion of point mutations and intragenic rearrangements of
COL5A1 and COL5A2 as previously stated [Ritelli et al., 2013].
Once excluded partially overlapping hereditary soft connective
tissue disorders on clinical grounds and, if considered necessary,
by molecular tools, all patients were classified as affected by JHS
(Brightoncriteriaonly), EDS–HT(Villefranche criteria forEDS–HT
only) or JHSþ EDS–HT (Brighton and Villefranche criteria), as
previously detailed [Castori et al., 2014a]. Both sets of criteria were
strictly applied. The clinical diagnosis of EDS–HT was attributed
only in presence of bothmajor criteria, while that of JHSwasfixed in
presence of both major, one major and two minor, or four minor
916 AMERICAN JOURNAL OF MEDICAL GENETICS PART Acriteria [Beighton et al., 1998; Grahame et al., 2000]. As EDS–HT is
considered the unique major Ehlers–Danlos syndrome subtype
lacking a confirmatory laboratory test [Mayer et al., 2013], diagnosis
remained clinical in all patients.Patients’ Evaluation
Age at examination, sex and handedness was registered in all
available subjects. GJH was primarily assessed by the BS [Beighton
et al., 1973]. This score is composed of fivemaneuvers: four of them
are tested passively on both sides of the body and one is tested
actively. BS is a 9-point evaluation with attribution of one point in
the presence of any of the following: (a) passive apposition of the
thumb to the flexor aspect of the forearm (one point for each hand),
(b) passive dorsiflexion of the V finger beyond 90˚ (one point for
each hand), (c) hyperextension of the elbow beyond 10˚ (one point
for eacharm), (d)hyperextensionof thekneesbeyond10˚ (onepoint
for each leg), (e) forwardflexionof the trunkwith theknees extended
and the palms resting flat on the floor. In non-collaborative subjects
(such as, toddlers and adults in wheelchair), the upper end of the
sum was reduced by one point by excluding the maneuver for
forward flexion of the trunk. In this case, the highest score was
8/8. The 5-point questionnaire was also used as a pre-screening tool
[Hakim andGrahame, 2003], but their results were not further used
for the present work as this tool was not yet included in any set of
diagnostic criteria. Range of motion (ROM) was also assessed for a
range of joints and group of joints not included in the BS. As well
representative of the entire human body, we selected temporoman-
dibular joint (TMJ) (hypermobile for a full opening of >50mm),
2nd–4th metacarpophalangeal (MCP) joints (hypermobile with a
dorsal passive extension >40˚), proximal and distal phalangopha-
langeal joints at 2nd–4th fingers (hypermobile with a dorsal active
extension>0˚), metatarsophalangeal (MTP) joint at 1st toe (hyper-
mobilewith adorsal passive extension>70˚), hip (hypermobilewith
an abduction with leg extended >45˚), ankle (hypermobile with a
passive dorsiflexion >30˚), neck in rotation (hypermobile for an
active rotation>90˚ at each side), and lateral flexion (hypermobile
for an active lateral flexion>45˚ at each side), thoracolumbar spine
in rotation (hypermobile for apassive rotation>30–45˚ at each side)
and lateral flexion (hypermobile for an active lateral flexion>35˚ at
each side). All standard values for these extra joints were extracted
and only slightly adapted from Clarkson [2012] and obtained with
the use of an orthopedic goniometer or a flexible tape. Presence of
hypermobility (interpretedasadichotomous feature: yesornot)was
registered on both sides.
A set of static orthopedic features were systematically registered at
direct examination and included: (fixed) subluxation of the distal ulna,
(fixed) subluxation of the first metacarpal bone, cubitus valgus, pectus
excavatum, pectus carinatum, dorsal hyperkyphosis (clinical examina-
tion), lumbar hyperlordosis (clinical examination), scoliosis (always of
mild degree in JHS/EDS–HT 20˚ at clinical/radiological examina-
tion),genuumvalgus,halluxvalgus, andin-toeinggait/metatarsusvarus.
History annotation comprised the site and number of past luxations/
subluxations and sprains. Presence of (recurrent) soft-tissue injuries
was registered also in presence of three or more episodes. Single or
multiple events of tendon and muscle ruptures were also registered.
Standard biometry included height (cm), weight (kg), and arm span(cm), from which the body-mass index (BMI) and arm span/height
ratio were calculated. As applied in routine clinical examination, in
patients>15 years of age, the presence of leptosomic/ectomorphic and
picnic/endomorphic built was established with a BMI <19 and >25,
respectively inboth sexes. “Dolichostenomelia”was establishedwith an
arm span/height ratio >1.03 according to the Brighton criteria
[Grahame et al., 2000]. Complementarily, an arm span/height ratio
<0.97 was arbitrarily considered indicative for “brachymelia.” The
presence ofwrist and thumb (Steinberg) sign (monolateral or bilateral)
was also documented. Data on upper/lower body segment ratio were
not available in both groups.
Data from the VC were limited compared to TC and did not
include joint mobility measurement outside the BS and selected
anthropometric and orthopedic features. ROMwasmeasured with
an orthopedic goniometer in the TC only, while the BS was
established subjectively. Such a difference was originally estab-
lished by the senior investigators of the two centers as a result of
partially divergent assessment approaches, still in according to
available diagnostic criteria. Indeed, both the Vilfefranche and
Brighton criteria do not explain how to measure ROT for BS score
calculation. Recently, a worldwide lack of consensus in the assess-
ment of joint mobility and the diagnosis of JHS/EDS–HT was
highlighted by a questionnaire study among European and Ameri-
can experts [Remvig et al., 2014].Statistical Analysis
A series of descriptive statistics were used to summarize pertinent
study information. Chi-square or Fisher’s exact test was performed
for the comparison of categorical variables. The linear regression
model was used to investigate possible relationship between contin-
uous variables. Comparison between the presence/absence of se-
lected features andcontinuousvariables (i.e., age at examinationand
BS) was performed using the Mann–Whitney non parametric test.
All P values were reported as 2-sided and P values< 0.01 denotes
statistically significant association. Multivariate logistic regression
analysis considering age, gender, and center was carried out to
examine the associations for each feature/or group of features being
studied. All analyses were performed by using the SPSS software
(SPSS version 21.0, SPSS Inc., Chicago, IL).
Phenotype and evolution of JHS/EDS–HT are extremely vari-
able [Castori, 2012; Castori et al., 2013]. The reasons for such a
variability are still obscure, but genetic heterogeneity may be a
major contributor. This could also explain as to why the molecular
basis of JHS/EDS–HT remains unraveled. The identification of
discrete sub-phenotypes seems a good approach to ease the future
molecular characterization of JHS/EDS–HT and/or to identify
clues for predicting developmental trajectories. For this reason,
we further explored our data searching for possible clusters of
discrete features within our patients’ sample. Multiple correspon-
dence analysis (MCA), which is a descriptive technique designed to
analyze simple 2-way and multi-way tables, was considered an
adequate tool to evaluate the possible relationship among selected
variables and identify specific profiles. Associations between fea-
tures are represented graphically in the MCA, which is a graphic
representation of the statistical relationships between distinct
features, whose position in the graphic is exclusively informative
TABLE I. Descriptive Features of the Two Study Groups—Joint Hypermobility and Joint Instability Complications
Feature Training Center (%) Validation Center (%) P-Value
No. of patients
Females 106 (85.5) 57 (87.7) 0.67
Males 18 (14.5) 8 (12.3)
Total 124 (100) 65 (100)
Age (years)
Median 32 37 0.2591
Range 2–73 5–70
Total 124 65
Beighton score
Median 6.00 4.00 <0.00011
Range 0–9 0–9
Total 124 65
Joint hypermobility, Beighton score
1st finger right 85 (68.5) 28 (43.1) 0.001
1st finger left 93 (75.0) 31 (47.7) <0.0001
5th finger right 87 (70.2) 16 (24.6) <0.0001
5th finger left 96 (77.4) 26 (40.0) <0.0001
Elbow right 42 (33.9) 38 (58.5) 0.002
Elbow left 60 (48.4) 35 (53.8) 0.48
Knee right 71 (57.3) 18 (27.7) <0.0001
Knee left 73 (58.9) 22 (33.8) 0.001
Spine 51 (41.5) 37 (56.9) 0.04
Total 124 65
Joint hypermobility, other sites
TMJ 46 (37.1) NA NA
2nd–4th MCPs right 84 (67.7) NA NA
2nd–4th MCPs left 87 (70.2) NA NA
2nd–4th PIPs right 40 (32.3) NA NA
2nd–4th PIPs left 50 (40.3) NA NA
2nd–4th DIPs right 58 (46.8) NA NA
2nd–4th DIPs left 61 (49.2) NA NA
MTPs right 51 (43.6) NA NA
MTPs left 52 (44.4) NA NA
Ankle right 32 (27.4) NA NA
Ankle left 32 (27.4) NA NA
Hip right 49 (41.9) NA NA
Hip left 49 (41.9) NA NA
Neck rotation right 38 (32.5) NA NA
Neck rotation left 35 (29.9) NA NA
Neck flexion right 57 (48.7) NA NA
Neck flexion left 56 (47.9) NA NA
Full spine rotation right 78 (66.7) NA NA
Full spine rotation left 78 (66.7) NA NA
Full spine flexion right 42 (35.9) NA NA
Full spine rotation left 44 (37.6) NA NA
Total 118-124
Dislocations
1–2 13 (10.5) 7 (10.8) 0.95
3–10 21 (16.9) 13 (20.0) 0.6
>10 42 (33.9) 18 (27.7) 0.39
Habitual/recurrent 8 (6.5) 10 (15.4) 0.05
Fingers 9 (7.3) 4 (6.2) 1.0
Wrists 9 (7.3) 7 (10.8) 0.41
Elbows 9 (7.3) 5 (7.7) 1.0
Shoulders 38 (30.6) 33 (50.8) 0.007
Heels 11 (8.9) 9 (13.8) 0.29
Knees/rotulae 22 (17.7) 13 (20.0) 0.7
(Continued)
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TABLE I. (Continued)
Feature Training Center (%) Validation Center (%) P-Value
Hips 31 (25.0) 19 (29.2) 0.53
TMJ 32 (25.8) 28 (43.1) 0.01
Vertebrae 3 (2.4) 2 (3.1) 0.79
Ribs 1 (0.8) 1 (1.5) 1.0
Total 124 65
Major sprains
1–2 10 (8.1) 10 (15.4) 0.12
3–10 18 (14.5) 13 (20.0) 0.33
>10 47 (37.9) 21 (32.3) 0.45
Habitual/recurrent 5 (4.0) 6 (9.2) 0.19
Fingers/wrists 12 (9.7) 6 (9.2) 0.92
Elbows 1 (0.6) 1 (1.5) 1.0
Heels 75 (60.5) 38 (58.5) 0.79
Knees 15 (12.1) 17 (26.2) 0.01
Total 124 65
3 or more soft tissue injuries
Feature 46 (37.1) 26 (40.0) 0.7
Total 124 65
Tendon ruptures
Feature 4 (3.2) 3 (4.6) 0.69
Total 124 65
Muscle ruptures
Feature 5 (4.1) 1 (1.5) 0.67
Total 122 65
Significant P-values below 0.01 are indicated in bold.
DIP, distal interphalangeal (joint); MCP, metacarpophalangeal (joint); MTP, metatarsophalangeal (joint); NA, not available; PIP, proximal interphalangeal (joint); TMJ, temporomandibular joint.
1Mann-Whitney U test.
918 AMERICAN JOURNAL OF MEDICAL GENETICS PART A[Greenacre, 1984; Lebart et al., 1984]. Features to be analyzed were
selected arbitrarily among those which can be easily interpreted as
dichotomic and are more representative of what is to date consid-
ered the JHS/EDS–HT “core phenotype.”RESULTS
The TC and VC included 124 and 65 patients, respectively, for a
total of 189 individuals from 2 to 73 years of age. Tables I and II
summarized rough data obtained in the TC and VC. Groups were
comparable for age and sex bias, with the well-known skewed sex
ratio due to an excess of affected females (Table I [Castori et al.,
2010b]). Significant differences were noted concerning the BS
range with a median score of six and four in the TC and VC,
respectively. Information on joint instability complications (i.e.,
dislocations, sprains, soft-tissue injuries, and ruptures) were com-
parable between groups with a few exceptions, including the
number of dislocations at shoulders which were more common
in the VC (Table I). Anthropometry and the rate of selected
orthopedic traits did not differ between groups (Table II).Beighton Score (and Age)
In previous ecologic studies, an inverse correlation between
BS and age was suggested for Italian patients [Castori et al.,
2011, 2014a]. In the present work, correlation between BS and
age at diagnosis was further investigated and a statistically
significant inverse relationship was confirmed in both groups,with a linear R square of 0.33 (P-value: <0.0001) and 0.17
(P-value: 0.001) in the TC and VC, respectively (Fig. 1A). This
phenomenon was comparable between the two groups
(P¼ 0.38).
In a pilot research on 50 JHS/EDS–HT Italian patients, we found
a cut-off of 33 years for the transition from a positive to a negative
BS [Castori et al., 2011]. In the present study, the same trend was
found in the TC group with a P-value of<0.0001, while borderline
P values were found in the VC (i.e., 0.02; Fig. 1B). Still in according
with our previous observations [Castori et al., 2011], we evaluated
the presence/absence of the single items of the BS by age at
examination (Table III). Results were different between groups.
In the TC, the mean age was significantly lower among individuals
with hypermobility at any single joint compared to those without,
except for the right knee and spine. In the VC, all results were
comparable between the two groups (i.e., presence and absence).Hypermobility in Other Joints (and Age)
In the TC, we also evaluated ROM in 21 additional joints or groups
of joints outside the five maneuvers of the BS (Table I). Figure 2
compares age at examination and presence/absence (dichotomic
trait) of joint hypermobility (i.e., ROM values above normal) for
each of these 21 extra joints. Statistically significant values were
obtained for all sites, except TMJ, MTP joints (bilateral), ankles
(bilateral), and spine (rotation). In these joints, median age, and
age range of patients showing (presence) and not showing (ab-
sence) hypermobility were comparable, while the median age of
TABLE II. Descriptive Features of the Two Study Groups—Anthropometry, Habitus and Orthopedic Traits
Feature Training Center (%) Validation Center (%) P-Value
BMI
Median 22.25 21.57 0.491
Range 16.16–35.16 15.24–36.33
Total 96 57
Arm span/height ratio
Median 1.045 NA NA
Range 0.91–1.073
Total 121
Habitus (BMI)
Leptosomic 15 (15.6) 10 (17.5) 0.76
Picnic 23 (24.0) 13 (22.8) 0.87
Total 96 (100) 57 (100)
Habitus (arm span)
Dolichostenomelia 30 (24.8) NA NA
Brachymelia 12 (9.9)
Total 121
Wrist sign
Right 26 (21.5) 9 (15.8) 0.37
Left 27 (22.3) 10 (17.5) 0.46
Monolateral 5 (4.1) 7 (12.3) 0.06
Bilateral 24 (19.8) 5 (8.8) 0.06
Total 121 57
Thumb sign
Right 11 (9.0) 4 (7.0) 0.78
Left 14 (11.5) 5 (8.8) 0.58
Monolateral 5 (4.1) 3 (5.3) 0.71
Bilateral 10 (8.2) 3 (5.3) 0.76
Total 121 57
Orthopedic traits
FDSDU right 81 (65.9) NA NA
FDSDU left 86 (69.4) NA NA
1st MCP subluxation right 7 (5.6) NA NA
1st MCP subluxation left 5 (4.0) NA NA
Pectus carinatum 5 (4.2) 1 (1.5) 0.33
Pectus excavatum 9 (7.5) 9 (13.8) 0.16
Dorsal hyperkyphosis 83 (67.5) 40 (61.5) 0.41
Lumbar hyperlordosis 86 (69.4) 44 (67.7) 0.82
Scoliosis (<20 degrees) 67 (54.0) 39 (60.0) 0.43
Cubitus valgus right 65 (52.4) 34 (52.3) 0.99
Cubitus valgus left 52 (41.9) 28 (43.1) 0.88
Genuum valgus right 61 (49.2) 22 (33.8) 0.04
Genuum valgus left 64 (51.6) 24 (36.9) 0.05
Flexible flatfoot right 72 (58.1) 33 (50.8) 0.34
Flexible flatfoot left 67 (54.0) 32 (49.2) 0.53
In-toeing gait right 10 (8.2) 7 (10.8) 0.56
In-toeing gait left 10 (8.2) 6 (9.2) 0.81
Hallux valgus right 33 (27.0) 26 (40.0) 0.07
Hallux valgus left 35 (28.7) 28 (43.1) 0.05
Total 120–124 65
BMI, body mass index; FDSDU, fixed dorsal subluxation of the distal ulna; MCP, metacarpophalangeal (joint); NA, not available.
1Mann-Whitney U test.
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FIG. 1. (A) Scatter plot showing inverse linear correlation between age at examination and Beighton score in the training center (white
circles) and validation center (inverse black triangles). In both cohorts an inverse correlation between Beighton score and age was
demonstrated. The P-value of the R square was <0.0001 and 0.001 in TC and VC, respectively. (B) Distribution of patients in both groups
with or without a positive Beighton score in relation to their age. A dichotomous distribution with a cut-off of 33 years was used according
to previous study.
920 AMERICAN JOURNAL OF MEDICAL GENETICS PART Apatients presenting the feature was significantly lower than those
without in all other joints.We also tried to use these 21 extra sites of
joint hypermobility as a tool complementary to BS. We arbitrarily
attributed one point to the presence and 0 point to the absence of
hypermobility in each joint (or group of joints), similarly to the five
maneuvers of the BS. The sum ranged from 0 (i.e., absence of all
extra hypermobile joints) to 21 (i.e., presence of all extra hyper-
mobile joints). Comparably to the BS (Fig. 1A), the overall scorediminished according to age at evaluation with a linear R square of
0.33 also for these extra joints (Fig. 3).Physical Examination and Sex
Differences between sexes concerning somatic manifestations were
minimal. Concerning the BS, an excess of hypermobile spine
(P-value: 0.007) were noted in women, while borderline P values
TABLE III. Difference in Age for Presence of Specific Beighton Score Items
Training center Validation center
Beighton score item Presence (years) Absence (years) P-Value Presence (years) Absence (years) P-Value
1st finger right
Mean 25.96 43.31 <0.0001 29.43 37.65 0.026
SD 14.525 12.321 14.315 15.120
1st finger left
Mean 27.00 44.68 <0.0001 31.84 36.18 0.193
SD 14.331 13.378 15.771 14.640
5th finger right
Mean 26.16 43.78 <0.0001 29.88 35.49 0.223
SD 14.754 11.485 15.213 15.130
5th finger left
Mean 27.89 43.54 <0.0001 30.88 36.26 0.166
SD 15.291 12.182 12.959 16.377
Elbow right
Mean 24.33 35.05 <0.0001 34.50 33.56 0.826
SD 14.069 15.802 16.688 13.189
Elbow left
Mean 26.33 36.19 0.001 30.97 37.77 0.1
SD 14.686 15.835 16.043 13.574
Knee right
Mean 28.17 35.77 0.015 26.94 36.85 0.032
SD 16.753 13.957 14.627 14.690
Knee left
Mean 28.19 36.04 0.009 27.64 37.42 0.016
SD 16.360 14.429 14.549 14.641
Spine
Mean 34.80 29.39 0.048 31.84 37.11 0.107
SD 14.502 16.545 15.833 14.106
Significant P-values below 0.01 are indicated in bold. P-values were calculated with the Mann–Whitney U test.
Mean and standard deviation are expressed in years.
SD, standard deviation.
MORLINO ET AL. 921were noted in males for an excess of hypermobile first (P-value:
0.04) andfifth (P-value: 0.01) fingers on the right in theTConly. All
other BS items were comparable between sexes in both groups. A
mean BS value higher in males (6.5) was registered in the TC only.
Table IV showed comparison of the other structural features
(hypermobility at extra joints, anthropometry and orthopedic
traits) between sexes. No differences were noted on anthropometry
and only a few significant divergences were registered for the other
features.Males resultedmore commonly hypermobile than females
at neck flexion (both sides), while females showedmore frequently
cubitus valgus on the left.Joint Instability Complications
In order to test whether age at ascertainment might relate with
presence of joint instability complications (i.e., dislocations,
sprains, and soft-tissue injuries) at history taking, patients
were arbitrarily stratified by age (i.e., 20 years, 21–30 years,
31–40 years, >40 years). Sites (dislocations and sprains only)
and rate of joint instability complications was evaluatedaccordingly (Table V). No major significant difference was
registered in term of positive report of previous dislocations
and sprains among age categories in both groups. Comparable
results were also obtained for sites of dislocations and sprains. A
significantly higher rate of soft tissue injuries (three or more
events) was registered in adults and elder of the TC only. Tendon
and muscle ruptures had a very low rate in both groups and, then,
may be considered occasional findings.Handedness
Patients from the TC were also investigated for a possible role of
handedness on the rate of joint hypermobility and bilateral ortho-
pedic traits. No significant difference was observed for fixed
subluxation of the distal ulnar epyphysis and 1st metacarpal,
genuum valgus, hallux valgus, cubitus valgus, in-toeing gait, flexible
flatfoot, and joint hypermobility at knee, elbow, 1st and 5th fingers,
2nd–4th distal and proximal interphalangeal joint of hands, meta-
carpophalangeal joint, spine (rotation and flexion), neck (rotation
and flexion), 1st metatarsophalangeal joint, ankles, and hips.
FIG. 2. Box plots comparing the presence (Y¼ yes) and absence (N¼ no) of joint hypermobility (i.e., an excessive range of motion) at 21
joints or groups of joints outside the Beighton score in relation with age at examination. The horizontal black line indicates the median value,
the upper box the first quartile, the lower box the remaining three quartiles, and the vertical line the entire range of values observed in the
patient sample.
FIG. 3. Scatter plot showing inverse linear correlation between
the presence of joint hypermobility at joints or groups of joints
(no. 21) outside the Beighton score and age at examination of
patients from the TC. For all joints, we attributed 1 point to their
presence and 0 points to their absence for a maximum total
of 21.
922 AMERICAN JOURNAL OF MEDICAL GENETICS PART AMultiple Correspondence Analysis and
Multivariate Logistic Regression Analysis
MCA for sex, BS (5 vs. <5) and eleven selected orthopedic, and
anthropometric traits did not depict a clear-cut clustering of
features in discrete physical subphenotypes (Fig. 4). Anyway,
low BS, brachymelia, and absence of the selected features (white
dots) tend to associate together with a net separation from high BS
and presence of orthopedic traits, dolichostenomelia according to
the Brighton criteria (arm span/height ratio >1.03) and arachno-
dactyly (positive wrist or Steinberg signs—the clinical definition of
arachnodactyly in JHS/ED–HT is a matter of debate and it will be
probably included in the future diagnostic criteria). Male sex,
pectus deformities, positive wrist sign, and flexible flatfoot are
the most divergent features. More specifically, positive wrist sign
tends to cluster with positive thumb sign, recurrent enthesopathies,
and hallux valgus; pectus deformities segregate with male sex and
associate with dolichostenomelia; and flexible flatfoot seems to
combine with brachymelia and low BS.
Statistical analyses carried out with an univariate approach was
further investigated with a multivariate logistic regression analysis.
Positive results (i.e., with a P-value< 0.01) were highlighted in
Table VI. Significant influence of sex and evaluation center was also
evident at the multivariate logistic regression analysis. Occasional
significancewas also registered for single orthopedic traits and joint
instability complications.
TABLE IV. Differences Between Sexes Within the Two Study Groups—Joint Hypermobility at Other Joints, Habitus and Orthopedic Traits
Training center (%)
Feature Females Males P-Value
Joint hypermobility, other sites
TMJ 38 (35.8) 8 (44.4) 0.48
2nd–4th MCPs right 68 (64.2) 16 (88.9) 0.04
2nd–4th MCPs left 71 (67.0) 16 (88.9) 0.06
2nd–4th PIPs right 32 (30.2) 8 (44.4) 0.23
2nd–4th PIPs left 42 (39.6) 8 (44.4) 0.70
2nd–4th DIPs right 49 (46.2) 9 (50.0) 0.77
2nd–4th DIPs left 52 (49.1) 9 (50.0) 0.94
MTPs right 40 (40.4) 11 (61.1) 0.10
MTPs left 40 (40.4) 12 (66.7) 0.04
Ankle right 29 (29.3) 3 (16.7) 0.39
Ankle left 29 (29.3) 3 (16.7) 0.39
Hip right 43 (43.4) 6 (33.3) 0.42
Hip left 43 (43.4) 6 (33.3) 0.42
Neck rotation right 33 (32.4) 5 (33.3) 0.99
Neck rotation left 30 (29.4) 5 (33.3) 0.76
Neck flexion right 45 (44.1) 12 (80.0) 0.009
Neck flexion left 44 (43.1) 12 (80.0) 0.008
Full spine rotation right 65 (63.7) 13 (86.7) 0.08
Full spine rotation left 65 (63.7) 13 (86.7) 0.08
Full spine flexion right 34 (33.3) 8 (53.3) 0.13
Full spine rotation left 36 (35.3) 8 (53.3) 0.18
Total 15–18 99–102
Habitus (BMI)
Leptosomic 14 (15.6) 1 (16.7) 0.99
Picnic 22 (24.4) 1 (16.7) 0.99
Total 90 6
Habitus (arm span)
Dolichostenomelia 24 (23.3) 6 (33.3) 0.38
Brachymelia 11 (10.7) 1 (5.6) 0.69
Total 103 18
Wrist sign
Right 24 (22.9) 2 (12.5) 0.52
Left 24 (22.9) 3 (18.8) 0.99
Monolateral 4 (3.8) 1 (6.3) 0.51
Bilateral 22 (21.0) 2 (12.5) 0.74
Total 105 16
Thumb sign
Right 10 (9.5) 1 (5.9) 0.99
Left 14 (13.3) 0 (0.0) 0.21
Monolateral 4 (3.8) 1 (5.9) 0.53
Bilateral 10 (9.5) 0 (0.0) 0.35
Total 105 17
Orthopedic traits
FDSDU right 73 (69.5) 8 (44.4) 0.04
FDSDU left 76 (71.7) 10 (55.6) 0.17
1st MCP subluxation right 6 (5.7) 1 (5.6) 0.99
1st MCP subluxation left 4 (3.8) 1 (5.6) 0.55
Pectus carinatum 3 (2.9) 2 (11.1) 0.11
Pectus excavatum 5 (4.9) 4 (22.2) 0.03
Dorsal hyperkyphosis 70 (66.0) 13 (76.5) 0.39
Lumbar hyperlordosis 75 (70.8) 11 (61.1) 0.41
Scoliosis (<20 degrees) 60 (56.6) 7 (38.9) 0.16
Cubitus valgus right 60 (56.6) 5 (27.8) 0.02
Cubitus valgus left 51 (48.1) 1 (5.6) 0.001
(Continued)
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TABLE IV. (Continued)
Training center (%)
Feature Females Males P-Value
Genuum valgus right 52 (49.1) 9 (50.0) 0.94
Genuum valgus left 54 (50.9) 10 (55.6) 0.72
Flexible flatfoot right 58 (54.7) 14 (77.8) 0.07
Flexible flatfoot left 54 (50.9) 13 (72.2) 0.09
In-toeing gait right 6 (5.7) 4 (23.5) 0.03
In-toeing gait left 6 (5.7) 4 (23.5) 0.03
Hallux valgus right 32 (30.5) 1 (5.9) 0.04
Hallux valgus left 33 (31.4) 2 (11.8) 0.15
Total 105–106 18
Significant P-values below 0.01 are indicated in bold.
Comparison by sex was not possible in the validation center due to the small number of patients.
DIP, distal interphalangeal (joint); MCP, metacarpophalangeal (joint); MTP, metatarsophalangeal (joint); NA, not available; PIP, proximal interphalangeal (joint); TMJ, temporomandibular joint.
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The leading purpose of this study is nosologic. Since the publication
of the two currently available diagnostic criteria for JHS and
EDS–HT in the late ’90s [Beighton et al., 1998; Grahame et al.,
2000], too little attention has been paid to the features detectable on
physical examination. In fact, in the last 5 years the number of
publications on JHS/EDS–HT has multiplied, but many of them
were limited to analyzing subjective symptoms or variables influ-
encingquality of life.However, thanks to the efforts of a few research
groups, JHS/EDS–HT is now a complex and truly “systemic”
disorder overlapping functional gastrointestinal disorders [Zarate
et al., 2010] and cardiovascular dysautonomia [De Wandele et al.,
2014]. Pain generation andmodulation in JHS/EDS–HT is a further
promising field of research in this condition [Rombaut et al.,
2015b]. It is likely that JHS/EDS–HT probably will remain for years
a clinical diagnosis recognized during consultation by accurate
physical examination. Now, it is clear enough that there is a lack
of consensus concerning the application of Brighton and Ville-
franche criteria and BS also among experts and such a confusion is
influenced by the lack of clinical research on the physical phenotype
and natural history of JHS/EDS–HT [Remvig et al., 2014; Castori
et al., 2014b]. The phenotypic continuity from apparently isolated
GJH on one end and JHS/EDS–HT on the other is difficulty
managed also in specialized setting, and this lays on the gap between
available diagnostic criteria and the increasing knowledge accumu-
lated in the last years.
The inverse relationship between age at diagnosis andROMand,
consequently, BS is known since 2007 [Remvig et al., 2007]. In the
present study, we confirmed that in Italian JHS/EDS–HT patients,
the BS is lower in adults and is often in the “negative” range (i.e.,
<5) since the fourth decade of life [Castori et al., 2011, 2014a,
2015]. This means that pediatric and young adult patients com-
monly have a “positive” BS at first ascertainment. Then, in the
presence of the typical but variable skin changes, they can be labeled
as EDS–HT according to Villefranche criteria. In the meantime,
adults and the elder rarely maintain or obtain a formal diagnosis of
EDS–HT due to their often low BS. Age was demonstrated as a
primary confounding factor in the mutual application of Brighton
and Villefranche criteria in a pedigree study on 23 families withJHS/EDS–HT [Castori et al., 2014a]. In this work, most families
showed a non-homogeneous distribution of the two clinical diag-
noses among the different generations, with an excess of EDS–HT
“alone” in children and JHS in adults and elders, and possibility of
co-morbidity in adolescents and middle-aged patients.
The question whether a patient with the suspect of a systemic
disorder has (had) or not GJH is relevant. In fact, the differential
diagnosis of such “complex” patients is not straightforward and
often include many rheumatologic and non-rheumatologic disor-
ders. In the presence of GJH and in the absence of chronic inflam-
mation, thediagnosisof JHS/EDS–HTis likely.Thenegative effectof
age on ROM was known in the past [Grahame et al., 2000; Remvig
et al., 2007]. Probably in line with such an assumption, the Brighton
criteria, which were originally defined in an adult rheumatologic
setting, include a lower BS (4) compared to the Villefranche
criteria (5) as a major criterion and also consider a BS value of
1–3 as aminor criterion. In addition, a simple 5-point questionnaire
was subsequently “unofficially” introduced in order to historically
check for GJH in symptomatic or asymptomatic patients who have
lost their earlier hypermobility [Hakim and Grahame, 2003].
In this study, we observed that age at diagnosis has some
relationship with the single items of the BS, as well as with the
ROM of 21 additional joints or group of joints. While the BS tends
to be lower in adults and elder in both groups, the link between age
at ascertainment and the presence/absence of the single BS items is
different in the two patients’ cohorts. In particular, the presence of
seven out of the nine maneuvers of the BS associate with a lower
mean age at diagnosis in the TC only. Furthermore, the mean BS is
overall higher in the TC than VC. The reasons for such a difference
remain obscure. Interestingly, while in the TC the BS was assessed
by the use of an orthopedic goniometer, this was not the case of the
VC where the evaluation of ROM was clinical. It may be inferred
that the routine use of an orthopedic goniometermay contribute to
this heterogeneity. Anyway, further elements, such as small sample
size, different personnel/centers, lack of standardization and not
comparable training background, could have influenced the diver-
gent results on BS between the two centers. In addition, there are
more differences between the TC and VC and no attempt was
carried out to explore the inter-examiner variability. This study
confirms the lack of a consensus in the assessment of the BS also
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FIG. 4. Multiple correspondence analysis for sex, Beighton score (as a dichotomic trait; i.e., 5 vs. <5) and eleven traits at physical
examination. All features are indicated by a circle with black circles indicating presence and white circles indicating absence. This analysis
was carried out in the training center only. Symbol legend: 1¼ sex (black¼males; while¼ females); 2¼ Beighton score (black¼ 5;
white¼< 5); 3¼ arm span (black >1.03; white¼< 0.97); 4¼ sternum deformities (black¼ yes; white¼ no); 5¼ thumb sign (black¼ yes;
white¼ no); 6¼wrist sign (black¼ yes; white¼ no); 7¼ flexible flatfoot (black¼ yes; white¼ no); 8¼ cubitus valgus (black¼ yes;
white¼ no); 9¼ genuum valgus (black¼ yes; white¼ no); 10¼ hallux valgus (black¼ yes; white¼ no); 11¼ recurrent dislocations
(black¼ yes; white¼ no); 12¼ recurrent sprains (black¼ yes; white¼ no); 13¼ recurrent soft-tissue injuries (black¼ yes; white¼ no).
Dimension 1 and dimension 2 indicate the Euclidean spatial nature of the multiple correspondence analysis.
926 AMERICAN JOURNAL OF MEDICAL GENETICS PART Aamong “expert” centers [Remvig et al., 2014] and the need of more
extended and multicentric studies for solving the issue.
A link between age at ascertainment and ROM of the 21 extra
joints outside the BS is also evident. The mean age of patients
showing hypermobility inmany of these joints is significantly lower
than the mean age of those with normal mobility at the same sites.
This occurs in all joints but not in ankles, MTP joints, TMJ, and
spine (in rotation), whosemobility, in turn, seemed less affected by
age. However, such a phenomenon is lost at multivariate logistic
regression analysis except for spine rotation on the left. Therefore,
the search for joints less influenced by age in order to identify a
more reliable scoring system for assessing GJH at different agesresults prohibitive. In order to more accurately assess for the
presence or absence of GJH, the routine evaluation of joints outside
the BSmay be helpful, especially when a full BS cannot be obtained
due to non-collaborative or disabled patients, or in presence of a
negative BS but a positive 5-point questionnaire.
Concerning joint instability complications, there is not any overt
association between age at ascertainment and their rate and loca-
tion. Multivariate logistic regression analysis demonstrated a link
between age at diagnosis and presence of three or more soft tissue
injuries only. Therefore, recurrent joint dislocations remain a valid
marker for JHS/EDS–HT although a consensus is still lacking
concerning number of dislocations and of affected joints for the
TABLE VI. Positive Results of the Multivariate Logistic Regression Analysis
Sex Age Center
Feature OR (CI 95%) P OR (CI 95%) P OR (CI 95%) P
Habitus, picnic 1.05 (0.20–5.60) 0.95 1.06 (1.02–1.09) 0.001 1.10 (0.49–2.49) 0.81
Beighton score
1st finger right 0.97 (0.30–3.10) 0.95 0.94 (0.91–0.96) <0.0001 3.08 (1.54–6.16) 0.001
1st finger left 0.78 (0.25–2.49) 0.68 0.94 (0.92–0.97) <0.0001 3.44 (1.73–6.85) <0.0001
5th finger right 1.74 (0.51–5.99) 0.38 0.94 (0.92–0.97) <0.0001 9.36 (4.27–20.51) <0.0001
5th finger left 0.96 (0.30–3.09) 0.94 0.95 (0.93–0.97) <0.0001 5.61 (2.78–11.34) <0.0001
Elbow right 1.51 (0.60–3.87) 0.38 0.98 (0.96–0.99) 0.03 0.32 (0.17–0.61) 0.001
Elbow left 0.91 (0.35–2.33) 0.84 0.96 (0.94–0.98) <0.0001 0.71 (0.38–1.34) 0.29
Knee right 0.89 (0.33–2.36) 0.81 0.96 (0.94–0.99) 0.001 3.46 (1.77k6.76) <0.0001
Knee left 1.18 (0.44–3.14) 0.75 0.97 (0.94–0.99) 0.001 2.74 (1.43–5.23) 0.002
Spine 0.40 (0.15–1.06) 0.07 1.01 (0.98–1.02) 0.98 0.54 (0.29–0.99) 0.05
Hypermobility, other joints
2nd–4th DIPs right 0.43 (0.13–1.41) 0.16 0.95 (0.92–0.98) <0.0001 NA NA
2nd–4th DIPs left 0.34 (0.10–1.16) 0.08 0.95 (0.92–0.97) <0.0001 NA NA
2nd–4th PIPs right 0.64 (0.19–2.13) 0.47 0.94 (0.91–0.97) <0.0001 NA NA
2nd–4th PIPs left 0.41 (0.12–1.37) 0.15 0.94 (0.92–0.97) <0.0001 NA NA
2nd–4th MCPs right 1.68 (0.31–9.05) 0.55 0.94 (0.92–0.97) <0.0001 NA NA
2nd–4th MCPs left 1.60 (0.30–8.50) 0.58 0.95 (0.92–0.98) 0.001 NA NA
Full spine rotation left 2.34 (0.47–11.80) 0.3 0.97 (0.94–1.0) 0.05 NA NA
Full spine flexion right 1.01 (0.29–3.50) 0.99 0.95 (0.92–0.98) 0.002 NA NA
Full spine flexion left 0.98 (0.29–3.37) 0.98 0.95 (0.93–0.98) 0.003 NA NA
Neck rotation right 0.46 (0.12–1.69) 0.24 0.95 (0.92–0.98) 0.003 NA NA
Neck rotation left 0.44(0.12–1.66) 0.23 0.94 (0.91–0.98) 0.001 NA NA
Neck flexion right 1.77 (0.38–8.33) 0.47 0.93 (0.90–0.96 <0.0001 NA NA
Neck flexion left 1.50 (0.29–7.67) 0.63 0.91 (0.88–0.95) <0.0001 NA NA
Hip right 0.23 (0.07–0.82) 0.02 0.95 (0.92–0.98) 0.001 NA NA
Hip left 0.23 (0.07–0.82) 0.02 0.95 (0.92–0.98) 0.001 NA NA
Orthopedic traits
FDSDU right 0.81 (0.25–2.62) 0.72 1.05 (1.02–1.08) 0.002 NA NA
FDSDU left 1.23 (0.38–4.03) 0.73 1.05 (1.02–1.09) 0.001 NA NA
1st MCP subluxation right NA 1.21 (1.08–1.36) 0.001 NA NA
1st MCP subluxation left NA 1.16 (1.05–1.28) 0.003 NA NA
Pectus excavatum 5.83 (1.77–19.27) <0.0001 0.96 (0.92–1.01) 0.06 0.34 (0.11–1.02) 0.06
Lumbar hyperlordosis 0.45 (0.17–1.17) 0.1 0.98 (0.95–0.99) 0.03 1.03 (0.53–1.99) 0.93
Cubitus valgus right 0.32 (0.12–0.84) 0.02 0.99 (0.98–1.02) 0.66 1.02 (0.55–1.88) 0.96
Cubitus valgus left 0.11 (0.03–0.40) <0.0001 0.98 (0.96–1.01) 0.13 0.96 (0.51–1.80) 0.89
Genuum valgus right 0.84 (0.34–2.09) 0.7 0.99 (0.98–1.02) 0.67 1.88 (1.01–3.51) 0.05
Genuum valgus left 1.58 (0.64–3.91) 0.32 1.01 (0.99–1.03) 0.43 1.85 (1.0–3.44) 0.05
In-toeing gait left 2.62 (0.75–9.17) 0.13 0.96 (0.92–1.0) 0.05 0.72 (0.24–2.20) 0.57
Hallux valgus right 0.99 (0.32–3.13) 0.99 1.05 (1.02–1.07) <0.0001 0.58 (0.30–1.14) 0.11
Hallux valgus left 1.25 (0.41–3.76) 1.05 1.05 (1.02–1.07) <0.0001 0.55 (0.28–1.08) 0.08
Dislocations
Number: 3–10 0.59 (0.12–2.84) 0.51 1.04 (1.01–1.06) 0.01 0.88 (0.40–1.93) 0.74
Number: habitual/recurrent 1.21 (0.29–5.05) 0.8 0.99 (0.96–1.03) 0.67 0.37 (0.14–0.99) 0.05
Site: Shoulders 0.67 (0.26–1.77) 0.42 0.99 (0.98–1.02) 0.68 0.43 (0.23–0.79) 0.007
Site: TMJ 0.67 (0.22–2.03) 0.67 1.02 (1.01–1.05) 0.04 0.48 (0.25–0.91) 0.02
Sprains
Number: >10 0.23 (0.06–0.84) 0.03 1.01 (0.99–1.03) 0.31 1.36 (0.71–2.60) 0.36
Site: knees 2.62 (0.83–8.26) 0.1 1.03 (0.99–1.06) 0.06 0.40 (0.18–0.88) 0.02
Three or more soft tissue injuries 0.50 (0.15–1.64) 0.25 1.05 (1.02–1.07) <0.0001 0.98 (0.51–1.89) 0.95
Significant P-values below 0.01 are indicated in bold.
CI, confidence interval; DIP, distal interphalangeal joint; FDSDU, fixed dorsal subluxation of the distal ulna; MCP, metacarpophalangeal (joint); MTP, metatarsophalangeal (joint); NA, not available; OR, odds
ratio; PIP, proximal interphalangeal (joint); TMJ, temporomandibular joints.
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tions of GJH in Italian patients but the high rate in the general
population limits their use as a diagnostic criterion. Based on our
preliminary study, recurrent (i.e., 3) soft-tissue injuries seems a
valid marker in adults but might lack sensitivity in children.
According to the generally accepted skewed sex ratio in JHS/
EDS–HT [Castori et al., 2010b], females were 6–7 times more
highly represented than males also in both study groups. Variable
explanations to this phenomenon have been recently put forward,
including an autosomal trait with sex-restricted modifying factors,
a complex disorder influenced by sexual dimorphism, and genetic
heterogeneity also including a X-linked dominant form [Castori
et al., 2011, 2014a]. Apparently in contrast with what was previ-
ously thought about the predominance of affected females and its
simplistic explanation relating to the different muscular build
between sexes, in this study JHS/EDS–HT males presented GJH
with a similar pattern compared to females (Table IV). This
phenomenon remains without a clear explanation, but may be
still in line with the tendency of an attenuated phenotype in males.
Accordingly, in males symptoms may present less frequently and
usually in those withmoremarked physical manifestations, such as
a positive or higher BS. Besides perhaps a slightly significant
increase of the mean BS in males, no other physical attribute seems
appropriate for distinguishing between sexes.
Typical habitus was heterogeneously reported feature of our
samples. The role of Marfanoid habitus was early recognized and
included in the Brighton criteria [Grahame et al., 2000]. More
recently, emphasis has been put on arachnodactyly as a powerful
marker for heritable connective tissue disorders in the routine
rheumatologic clinic [Grahame and Hakim, 2013]. Habitus is not
included in the Villefranche criteria for EDS–HT and the original
habitus item from the Brighton criteria does not offer any guidance
on the relative weight that dolichostenomelia and arachnodactyly
carry in the attribution of the criterion. In our samples, dolichos-
tenomelia, positivewrist sign andpositive thumb signwere reported
in 25%, 20–24%, and 10–12% of the patients. Interestingly,
dolichostenomelia and arachnodactyly did not combine together
in our sample (Fig. 4). Therefore, our finding seems suggesting
independence of the two sub-features during the assessment of the
habitus in JHS/EDS–HT. Anthropometry was also independent
from the distribution of the subcutaneous fat and BMI. We feel
that in the past confusion could had occurred in the distinction
between a true Marfanoid habitus and a leptosomic built (i.e.,
BMI< 19). Therefore, accurate anthropometric information is
necessary before the attribution of the habitus criterion and further
consensus is needed concerning the minimal number of positive
maneuvers requested for establishing the presence of arachnodac-
tyly. The middle finger length/total hand length ratio could be a
useful andmore objective surrogate of thewrist and thumb signs but
systematic studies are still lacking in JHS/EDS–HT.
In summary, this work highlights the need of applying some
adjustments for age concerning the assessment of GJH with minor
emphasis on sexual dimorphism; the existence of a very few joints
within and outside the BS that show a comparable ROM at the
different ages at ascertainment; the high diagnostic value of recur-
rent and multiple-site dislocations compared with other joint
instability complications; and the heterogeneity of orthopedicmanifestations with dolichostenomelia and arachnodactyly occur-
ing independently. We hope that our findings could support the
future revision of the criteria presently defining the overlapping
phenotypes of JHS and EDS–HT.ACKNOWLEDGMENTS
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